PULM (Pulmatrix) Aset Bersih Perusahaan

The Pulmatrix, Inc. (PULM) biopharmaceutical model is vulnerable due to the early stages of development for lung treatments, leaving it dependent on test results. This price action chart helps track these risks when the indicator is 0.00. The business relies on stable imports of chemical components to maintain high profitability, while unique delivery method patents and strict FDA oversight protect the company from generic competition.

PULM Kapitalisasi Buku Pulmatrix Corporation (04.07.2022 - 27.10.2026)

Rincian metrik lan analitis perusahaan Pulmatrix (PULM)

- rega lan prakiraan konsensus rega:

Bagan rega Pulmatrix Corporation|PULM - Bagan rega target

- data kapitalisasi pasar:

Biji pasar Pulmatrix Inc|PULM - Nilai Total Perusahaan

- data kapitalisasi buku:

Nilai Buku Saham Pulmatrix|PULM - Kapitalisasi Buku|Nilai Pasar marang Nilai Buku pulmatrix.com|PULM - Total Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal Pulmatrix, Inc.|PULM - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Pulmatrix Inc|PULM - Utang perusahaan|Utang marang nilai buku Pulmatrix Inc

Pambiji fundamental:PULM - Pulmatrix Corporation

Developing innovative inhalation drugs for the therapy of respiratory pathologies requires significant capital expenditures in powder delivery technology. By analyzing the company's capitalization on the balance sheet, an investor assesses the residual value of equity minus all liabilities, which allows for the determination of the real material base of Pulmatrix, Inc. (PULM) and confirms the stability of quotes through compliance with listing requirements.

Analisis pesaing Pulmatrix, Inc.

HLN: Nilai Buku Perusahaan|KVUE (Kenvue Inc.) - Nilai Buku Perusahaan|VRNA (veronapharma.com) - Aset Bersih Perusahaan|Nilai Buku Perusahaan Jyong Biotech MENS|Nilai Aset Bersih Ligand Pharmaceuticals Incorporated|Amneal Pharmaceuticals Inc (AMRX) - Kapitalisasi Buku|Nilai Akuntansi Perusahaan Perrigo Corp (PRGO)|Kapitalisasi Buku ALVO (Alvotech)|liquidia.com - Kapitalisasi Buku|Nilai Buku Perusahaan Galapagos (GLPG)|ANIP: Nilai Akuntansi Perusahaan|MNKD (MannKind Corp.) - Nilai Buku Perusahaan|Amphastar Corp (AMPH) - Aset Bersih Perusahaan|PCRX (Pacira BioSciences) - Kapitalisasi Buku|Kapitalisasi Buku ars-pharma.com (SPRY)|Theravance Biopharma, Inc. (TBPH) - Aset Bersih Perusahaan|Nilai Akuntansi Perusahaan AQST (Aquestive Therapeutics Inc)|SCPH: Nilai Buku Perusahaan|TECX - Ekuitas Perusahaan|Aset Bersih Perusahaan Tonix Pharmaceuticals TNXP|SXTC - Total Aset Bersih|Kapitalisasi Buku eupraxiapharma.com EPRX|BioHarvest Sciences, Inc. (BHST) - Nilai Akuntansi Perusahaan|Kapitalisasi Buku EXOZ (Invizyne Technologies, Inc.)|Ekuitas Perusahaan ORMP|Entera Bio Ltd. (ENTX) - Nilai Buku Perusahaan|Nilai Akuntansi Perusahaan HYFT (ipatherapeutics.com)|ABVC BioPharma, Inc. (ABVC) - Nilai Buku Perusahaan|CPIX - Nilai Aset Bersih|Quantum BioPharma Limited - Aset Bersih Perusahaan|FGEN: Kapitalisasi Buku|Telomir Pharmaceuticals (TELO) - Nilai Buku Perusahaan|RANI (Rani Therapeutics Holdings, Inc.) - Nilai Buku Perusahaan|Nilai Buku Perusahaan SNYR|Aset Bersih Perusahaan Rallybio Corp.|Kapitalisasi Buku LEXX|Kapitalisasi Buku ftzy.com.cn PTHL|Aset Bersih Perusahaan Aptorum Group (APM)|lyratherapeutics.com - Total Aset Bersih|Nilai Buku Perusahaan Impact BioMedical Inc (IBO)|TNFA - Nilai Akuntansi Perusahaan|cbdmd.com - Kapitalisasi Buku|Pambiji Buku Bisnis PainReform Corp|Aset Bersih Perusahaan Altamira Therapeutics Ltd (CYTO)|Kapitalisasi Akuntansi lipella.com (LIPO)|OptiNose (OPTN) - Aset Bersih Perusahaan|Nilai Akuntansi Perusahaan Pieris Pharmaceuticals Inc (PIRS)|Kapitalisasi Buku PROC|Petros Pharma - Pambiji Buku Bisnis|Qilian International (QLI) - Nilai Buku Perusahaan|SLRN - Kapitalisasi Akuntansi|TFFP (TFF Pharmaceuticals, Inc.) - Kapitalisasi Buku